Tempus AI Buys Personalis in $1.7 Billion Precision Oncology Deal - TradingView

A biotech AI company is buying another precision medicine company for $1.7 billion, signaling major investment in AI for healthcare and cancer treatment. This matters because it shows how AI is being used to develop better medical diagnostics and treatments.